Correspondence 0001818382-23-000080 from Humacyte, Inc. (HUMA)

Humacyte, Inc.
Date: June 16, 2023 · CIK: 0001818382 · Accession: 0001818382-23-000080

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-272550

Date

June 16, 2023

Author

Dale A. Sander

Form

CORRESP

Company

Humacyte, Inc.

Letter

Document

June 16, 2023

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Alan Campbell

Re: Humacyte, Inc.

Registration Statement Filed on Form S-3 (the “Registration Statement”)

File No. 333-272550

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Humacyte, Inc. (the “Company”) hereby respectfully requests that the effective date for the above-referenced Registration Statement be accelerated to 4:00 p.m., Eastern Time, on June 21, 2023, or as soon as practicable thereafter.

Please contact Kerry S. Burke of Covington & Burling LLP at (202) 662-5297 or kburke@cov.com with any questions you may have regarding this request. In addition, please notify Ms. Burke by telephone when this request for acceleration has been granted.

Respectfully,
Humacyte, Inc.

Show Raw Text

CORRESP
1
filename1.htm

Document

June 16, 2023

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Alan Campbell

Re: Humacyte, Inc.

 Registration Statement Filed on Form S-3 (the “Registration Statement”)

 File No. 333-272550

Ladies and Gentlemen:

    Pursuant to Rule 461 under the Securities Act of 1933, as amended, Humacyte, Inc. (the “Company”) hereby respectfully requests that the effective date for the above-referenced Registration Statement be accelerated to 4:00 p.m., Eastern Time, on June 21, 2023, or as soon as practicable thereafter.

    Please contact Kerry S. Burke of Covington & Burling LLP at (202) 662-5297 or kburke@cov.com with any questions you may have regarding this request. In addition, please notify Ms. Burke by telephone when this request for acceleration has been granted.

 Respectfully,

 Humacyte, Inc.

 By:  /s/ Dale A. Sander

 Name:   Dale A. Sander

 Title:  Chief Financial Officer

cc:  Kerry S. Burke, Covington & Burling LLP

SecProbe.io